Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
21.48
-1.00 (-4.43%)
At close: Nov 4, 2024, 4:00 PM
20.40
-1.08 (-5.03%)
After-hours: Nov 4, 2024, 4:37 PM EST

KNSA Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Revenue
384.1270.26220.1838.54--
Upgrade
Revenue Growth (YoY)
54.41%22.74%471.24%---
Upgrade
Cost of Revenue
149.6689.9346.979.94--
Upgrade
Gross Profit
234.44180.33173.2128.61--
Upgrade
Selling, General & Admin
164.22129.4397.9585.9545.3234.96
Upgrade
Research & Development
96.4676.165.4999.3112.04135
Upgrade
Operating Expenses
260.68205.52163.44185.25157.36169.96
Upgrade
Operating Income
-26.24-25.29.77-156.64-157.36-169.96
Upgrade
Interest & Investment Income
-----6.05
Upgrade
Other Non Operating Income (Expenses)
9.518.541.250.11.13-
Upgrade
Pretax Income
-16.72-16.6511.03-156.54-156.23-163.91
Upgrade
Income Tax Expense
-7.66-30.74-172.341.395.15-2.05
Upgrade
Net Income
-9.0714.08183.36-157.92-161.38-161.87
Upgrade
Net Income to Common
-9.0714.08183.36-157.92-161.38-161.87
Upgrade
Net Income Growth
--92.32%----
Upgrade
Shares Outstanding (Basic)
717069696254
Upgrade
Shares Outstanding (Diluted)
717270696254
Upgrade
Shares Change (YoY)
1.53%2.13%2.69%10.89%14.42%82.92%
Upgrade
EPS (Basic)
-0.130.202.64-2.30-2.61-2.99
Upgrade
EPS (Diluted)
-0.130.202.60-2.30-2.61-2.99
Upgrade
EPS Growth
--92.31%----
Upgrade
Free Cash Flow
11.113.175.7-126.71-136.82-161.57
Upgrade
Free Cash Flow Per Share
0.160.180.08-1.85-2.21-2.99
Upgrade
Gross Margin
61.04%66.72%78.67%74.22%--
Upgrade
Operating Margin
-6.83%-9.32%4.44%-406.38%--
Upgrade
Profit Margin
-2.36%5.21%83.28%-409.72%--
Upgrade
Free Cash Flow Margin
2.89%4.87%2.59%-328.75%--
Upgrade
EBITDA
-24.4-22.8612.18-154.28-154.96-167.9
Upgrade
EBITDA Margin
-6.35%-8.46%5.53%---
Upgrade
D&A For EBITDA
1.842.342.42.362.412.07
Upgrade
EBIT
-26.24-25.29.77-156.64-157.36-169.96
Upgrade
EBIT Margin
-6.83%-9.32%4.44%---
Upgrade
Revenue as Reported
384.1270.26220.1838.54--
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.